ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1982

Senescent Synoviocytes in Knee Osteoarthritis Correlate with Disease Biomarkers, Synovitis, and Knee Pain

Christopher Yohn 1, Robert O'Brien 1, Stephanie Lussier 1, Casey Berridge 1, Rathi Ryan 1, Ali Guermazi 2, Mahru An 1, Remi-Martin Laberge 1, Benjamin Hsu1, Carl Millward 1, Kate Doherty 1 and Jamie Dananberg 1, 1Unity Biotechnology, Brisbane, CA, 2Boston Medical Center, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: biomarkers and synovial cells, Osteoarthritis, Senescent Cells, synovial fluid, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Background/Purpose:  Cellular senescence is a natural state in which a cell permanently halts division through upregulation of a set of intracellular proteins including p16INK4A in response to various cellular stressors.  Senescent cells secrete factors collectively referred to as the Senescence Associated Secretory Phenotype (SASP) that are proinflammatory and degradative in the local tissue environment. With aging, senescent cells accumulate in multiple tissues, and senolytic therapies are being developed to address age-related diseases. We conducted a clinical study to evaluate the relationship between the accumulation of senescent cells in OA knee synovial tissue and SASP/OA biomarkers, OA severity, and knee pain.

Methods: Methods:  This was a non-drug, cross-sectional, single-center study of 30 patients with symptomatic, radiographic, femoro-tibial knee OA (defined by a modified version of the American College of Rheumatology Criteria) for ≥6 months. Synovial biopsies were obtained arthroscopically and analyzed for the presence of p16Ink4A positive cells by immunohistochemistry. Blood, urine, and synovial fluid were collected for measurement of candidate biomarkers. Fixed-flexion, standing radiographs of the knees and gadolinium contrast-enhanced (CE)-MRI scans were performed and analyzed respectively for Kellgren-Lawrence (KL) grade and 11-point semiquantitative synovitis score.  Patients completed the Knee Injury and Osteoarthritis Outcome Score (KOOS) Survey, from which were derived WOMAC pain subscale scores.  Correlation analyses of senescence burden (i.e. percent of p16Ink4A positive synoviocytes) to candidate biomarkers in synovial fluid, plasma, serum and urine, and to MRI-based synovitis scores, KL grades, WOMAC pain scores, were done. Partial correlation coefficients after adjustment for age, BMI, and KL grade were determined.

Results: Results:  The study cohort had a mean age of 59 yrs, 47% were women, 77% white, and 93% had a KL grade of 2 or higher.  Consistent with findings in ex vivo studies of human OA knee specimens and a surgically-induced OA model in mice, we detected p16Ink4A positive, senescent cells in synovial biopsies from OA patients.  Moreover, the percent of p16Ink4A positive synoviocytes correlated significantly with a number of protein biomarkers in synovial fluid and plasma; the most strongly correlated was synovial fluid interleukin-6 (IL-6). Senescent synoviocytes also correlated significantly with the degree of synovitis (range 0-2) at the site of biopsy as assessed by the MRI-based synovitis score.  A trend for the correlation between senescent synoviocytes and KL grade 1 to 4 was observed; when restricting to patients with KL grades 1 to 3, the correlation was statistically significant.  Interestingly, the percent of senescent synoviocytes was also moderately correlated with pain as measured by the WOMAC-A pain subscale.

Conclusion: Conclusion:  This cross-sectional study provides further evidence for a relationship between the accumulation of senescent cells in the OA joint, SASP secretion, pain symptoms, and structural changes of knee OA.  It supports investigation of senolytics as a therapy for OA.


Disclosure: C. Yohn, UNITY Biotechnology, 1, 3, 4; R. O'Brien, UNITY Biotechnology, 1, 3, 4; S. Lussier, UNITY Biotechnology, 1, 3, 4, UNITY Biotechnology, 1, 3, 4; C. Berridge, UNITY Biotechnology, 3, 4; R. Ryan, UNITY Biotechnology, 3, 4; A. Guermazi, AstraZeneca, 5, BICL, 1, Boston Imaging Core Lab (BICL), 1, Galapagos, 5, MerckSerono, 5, Pfizer, 5, Roche, 5, Shareholder BICL,LLC, 1, TissueGene, 5; M. An, UNITY Biotechnology, 1, 3, 4; R. Laberge, UNITY Biotechnology, 1, 3, 4; B. Hsu, UNITY Biotechnology, 3, 4; C. Millward, UNITY Biotechnology, 3, 4; K. Doherty, UNITY Biotechnology, 1, 3; J. Dananberg, UNITY Biotechnology, 1, 3, 4, 6.

To cite this abstract in AMA style:

Yohn C, O'Brien R, Lussier S, Berridge C, Ryan R, Guermazi A, An M, Laberge R, Hsu B, Millward C, Doherty K, Dananberg J. Senescent Synoviocytes in Knee Osteoarthritis Correlate with Disease Biomarkers, Synovitis, and Knee Pain [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/senescent-synoviocytes-in-knee-osteoarthritis-correlate-with-disease-biomarkers-synovitis-and-knee-pain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/senescent-synoviocytes-in-knee-osteoarthritis-correlate-with-disease-biomarkers-synovitis-and-knee-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology